Some context worth noting: - Generic pricing could fall to ~50% of brand cost with two generics, and ~35% with three or more - Canadian insurers paid $77M in weight-loss drug claims in 2024, double the year before - 13 cancers are linked to obesity, and 2030% of cancer patients also have diabetes, heart disease, or mental health conditions, treating these in isolation misses the bigger picture, and leaves real clinical and financial value on the table
Sethi BK, Viswanathan V, Kumar A, et al
However, context matters here
The changes are subtle at first, then become more pronounced
Berberine in Non-Alcoholic Fatty Liver Disease a review
Don't wait for a patient portal response for any of these